Similar Search Results

Microeconomic essays on market entry, optimal education, and measured experience

Regan, Tracy L. - 2003

Persistent link: https://www.econbiz.de/10003385480

Should pharmaceutical costs be curbed?

Brekke, Kurt R.; Dalen, Dag Morten; Strøm, Steinar - In: Nordic economic policy review (2012) 2, pp. 247-273

Persistent link: https://www.econbiz.de/10010379568

Generic Drugs in Spain : Price Competition versus Moral Hazard

Moreno-Torres, Iván - 2011

This paper examines competition between generic and brand-name drugs in the regulated Spanish pharmaceutical market. A …

Persistent link: https://www.econbiz.de/10013124302

Optimal price regulations in international pharmaceutical markets with generic competition

Geng, Difei; Saggi, Kamal - In: Journal of health economics 71 (2020), pp. 1-19

Persistent link: https://www.econbiz.de/10012494335

Implementing personalized medicine with asymmetric information on prevalence rates

Antoñanzas Villar, Fernando; Juárez-Castelló, Carmelo A. - In: Health economics review 6 (2016) 35, pp. 1-8

Although personalized medicine is becoming the new paradigm to manage some diseases, the economics of personalized medicine have only focused on assessing the efficiency of specific treatments, lacking a theoretical framework analyzing the interactions between pharmaceutical firms and healthcare...

Persistent link: https://www.econbiz.de/10011586604

Estimating the causal effect of entry on generic drug prices using Hatch-Waxman exclusivity

Olson, Luke M.; Wendling, Brett W. - In: Review of industrial organization : RIO 53 (2018) 1, pp. 139-172

Persistent link: https://www.econbiz.de/10012009099

Endogenous versus exogenous generic reference pricing for pharmaceuticals

Antoñanzas Villar, Fernando; Juárez-Castelló, C. A.; … - In: International journal of health economics and management 17 (2017) 4, pp. 413-432

Persistent link: https://www.econbiz.de/10011814176

Price competition in pharmaceuticals : evidence from 1303 Swedish markets

Granlund, David; Bergman, Mats A. - In: Journal of health economics 61 (2018), pp. 1-12

Persistent link: https://www.econbiz.de/10011999624

Regulation, Generic Competition and Pharmaceutical Prices : Theory and Evidence from a Natural Experiment

Brekke, Kurt Richard; Holmas, Tor Helge; Straume, Odd Rune - 2014

We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a unique policy … experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products … that RP increases generic competition, resulting in lower brand-name market shares. Finally, we show that RP has a strong …

Persistent link: https://www.econbiz.de/10014198115

More cost-sharing, less cost? : evidence on reference price drugs

Herr, Annika; Stühmeier, Torben; Wenzel, Tobias - In: Health economics 32 (2023) 2, pp. 413-435

Persistent link: https://www.econbiz.de/10014266816